Format

Send to

Choose Destination
J Bone Jt Infect. 2018 Sep 7;3(4):182-186. doi: 10.7150/jbji.27718. eCollection 2018.

Prolonged Cefoxitin Infusion Using Mobile Elastomeric Infusors In Outpatients With Bone And Joint Infection.

Cavalli Z1,2, Becker A2,3,4, Bosch A2,3,4, Conrad A2,3,4, Triffault-Filit C2,3,4, Valour F2,3,4,5, Laurent F2,4,5,6, Cohen S7, Chidiac C2,3,4, Ferry T2,3,4,5.

Author information

1
Service de Maladies Infectieuses, Hôpital de Mercy, Centre Hospitalier Régional Metz-Thionville, France.
2
Université Claude Bernard Lyon 1, Lyon, France.
3
Service de Maladies Infectieuses, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, France.
4
Centre Interrégional de Référence des Infections Ostéo-articulaires complexes (CRIOAc Lyon), Hospices Civils de Lyon, France.
5
Centre International de Recherche en Infectiologie, CIRI, Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, Lyon, France.
6
Laboratoire de Bactériologie, Institut des Agents Infectieux, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, France.
7
Laboratoire de Biochimie, Unité de pharmacologie et toxicologie, Hospices Civils de Lyon, France.

Abstract

We reviewed all outpatients with bone and joint infection treated with cefoxitin in continuous intravenous infusion using mobile elastomeric infusors in our regional reference center between 2014 and 2017. The stability of cefoxitin provides an interesting and well-tolerated alternative for continuous infusion in outpatients with polymicrobial bone and joint infection.

KEYWORDS:

bone; cefoxitin; infusor; joint

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

Supplemental Content

Full text links

Icon for Ivyspring International Publisher Icon for PubMed Central
Loading ...
Support Center